首页|PIK/Akt/mTOR信号通路在肺腺癌不同EGFR突变状态中的临床相关研究与预测价值

PIK/Akt/mTOR信号通路在肺腺癌不同EGFR突变状态中的临床相关研究与预测价值

Clinical correlation and predictive value of PIK/Akt/mTOR signaling pathway in different EGFR mutation states of lung adenocarcinoma

扫码查看
目的 探讨PIK/Akt/mTOR信号通路在肺腺癌不同表皮生长因子受体(EGFR)突变状态中与患者临床特征的相关性与预测价值.方法 采用二代基因测序法(NGS)检测342例2010-2019年于本院明确诊断肺腺癌的患者,其中DNA总量不少于150 ng,DNA降解程度≥C级,根据是否有EGFR突变将患者分为阳性组与阴性组,比较两组在肺腺癌患者不同临床病理特征中的分布差异;根据PIK/Akt/mTOR信号通路在342例肺腺癌患者中的分布情况,分析PIK/Akt/mTOR信号通路与EGFR不同突变状态和淋巴结转移的相关性,以及PIK信号通路在EG-FR不同突变状态中的分布差异及与T790M突变状态的相关性.使用多元Logistic回归分析影响EGFR基因突变的因素.结果 (1)60岁以下的肺腺癌患者更易发生EGFR突变;(2)磷脂酰肌醇-4,5-双磷酸3-激酶催化亚基α(PIK3CA)、磷脂酰肌醇3-激酶(PIK3CG)表达阳性的患者EG-FR的突变频率更高;(3)PIK3CA突变阳性患者更易诱导T790M耐药突变;(4)PIK3CB、mTOR表达阳性的肺腺癌患者更易发生淋巴结转移.(5)年龄、PIK3CA、PIK3CG表达水平是预测EGFR突变的危险因素(P<0.05).结论 肺腺癌EGFR突变在60岁以下的患者中更常见,PIK3CA、PIK3CG的表达与EGFR基因突变具有相关性,PIK3CA的阳性表达可能参与调节T790M耐药突变的发生,PIK3CB、mTOR表达阳性会增加肺腺癌患者淋巴结转移的风险,年龄、PIK3CA、PIK3CG是预测EGFR突变的危险因素.
Objective To investigate the correlation and predictive value of PIK/Akt/mTOR signaling path-way with clinical features of lung adenocarcinoma in different EGFR mutation states.Methods The sec-ond-generation gene sequencing(NGS)was used to detect 342 patients with lung adenocarcinoma diag-nosed in the hospital from 2010 to 2019.The total amount of DNA should be no less than 150 ng,and the degree of DNA degradation should be≥C.According to whether there was EGFR mutation,the patients were divided into positive group and negative group,and the distribution differences between the 2 groups in different clinicopathological characteristics of lung adenocarcinoma patients were compared.According to the distribution of PIK/Akt/mTOR signaling pathway in 342 patients with lung adenocarcinoma,the correlation between PIK/Akt/mTOR signaling pathway and different mutation states and lymph node me-tastasis of EGFR,as well as the distribution difference of PIK signaling pathway in different mutation states of EGFR and its correlation with T790M mutation state were analyzed.Multivariate Logistic regres-sion was used to analyze the factors affecting EGFR gene mutation.Results(1)The patients with lung adenocarcinoma under 60 years old were more prone to EGFR mutation;(2)The mutation frequency of EGFR in patients with positive expression of phosphatidylinositol-4,5-bisphosphate 3-kinase subunit α(PIK3CA)and phosphatidylinositol 3-kinase(PIK3CG)was higher;(3)The patients with PIK3CA mu-tation were more likely to induce T790M drug-resistant mutation;(4)Lung adenocarcinoma patients with positive expression of PIK3CB and mTOR were more likely to have lymph node metastasis.(5)Age,PIK3CA and PIK3CG expression levels were risk factors for predicting EGFR mutation(P<0.05).Con-clusion EGFR mutation in lung adenocarcinoma was more common in patients under 60 years old.The expression of PIK3CA and PIK3CG was related to EGFR gene mutation.The positive expression of PIK3CA may be involved in regulating the occurrence of T790M drug-resistant mutation.The positive ex-pression of PIK3CB and mTOR will increase the risk of lymph node metastasis in lung adenocarcinoma pa-tients.Age,PIK3CA and PIK3CG were risk factors for predicting EGFR mutation.

lung adenocarcinomaEGFR mutationPIK signaling pathwayPIK3CAPIK3CBPIK3CG

摆惠芹、加孜那·托哈依

展开 >

新疆医科大学第一附属医院呼吸与呼吸危重症中心, 乌鲁木齐 830054

肺腺癌 EGFR突变 PIK信号通路 PIK3CA PIK3CB PIK3CG

国家重点研发计划

2017YFC0909900

2024

新疆医科大学学报
新疆医科大学

新疆医科大学学报

CSTPCD
影响因子:0.76
ISSN:1009-5551
年,卷(期):2024.47(3)
  • 28